Berlex' Ultravist x-ray/CT imaging agent approved May 10; launch slated for July.
This article was originally published in The Gray Sheet
Executive Summary
BERLEX ULTRAVIST CONTRAST AGENT WILL BE AVAILABLE IN JULY, the company announced May 12. The iodinated, non-ionic contrast agent iopromide for x-ray imaging and computed tomography scanning was approved by FDA on May 10, almost two years after FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval for eight indications ("The Gray Sheet" May 31, 1993, p. 14).